Full View

MYC and therapy resistance in cancer: risks and opportunities

G Donati, B Amati - Molecular oncology, 2022 - Wiley Online Library
The MYC transcription factor, encoded by the c‐MYC proto‐oncogene, is activated by
growth‐promoting signals, and is a key regulator of biosynthetic and metabolic pathways …
被引用次数：31 相关文章

MYC and therapy resistance in cancer: risks and opportunities

G Donati, B Amati - Molecular oncology, 2022 - pubmed.ncbi.nlm.nih.gov
The MYC transcription factor, encoded by the c-MYC proto-oncogene, is activated by growth-
promoting signals, and is a key regulator of biosynthetic and metabolic pathways driving cell …

MYC and therapy resistance in cancer: risks and opportunities

G Donati, B Amati - Molecular Oncology, 2022 - search.proquest.com
The MYC transcription factor, encoded by the c‐MYC proto‐oncogene, is activated by
growth‐promoting signals, and is a key regulator of biosynthetic and metabolic pathways …

MYC and therapy resistance in cancer: risks and opportunities.

G Donati, B Amati - Molecular Oncology, 2022 - europepmc.org
The MYC transcription factor, encoded by the c‐MYC proto‐oncogene, is activated by
growth‐promoting signals, and is a key regulator of biosynthetic and metabolic pathways …
[HTML] nih.gov

[HTML][HTML] MYC and therapy resistance in cancer: risks and opportunities

G Donati, B Amati - Molecular Oncology, 2022 - ncbi.nlm.nih.gov
The MYC transcription factor, encoded by the c‐MYC proto‐oncogene, is activated by
growth‐promoting signals, and is a key regulator of biosynthetic and metabolic pathways …

MYC and therapy resistance in cancer: risks and opportunities.

G Donati, B Amati - Molecular Oncology, 2022 - europepmc.org
The MYC transcription factor, encoded by the c-MYC proto-oncogene, is activated by growth-
promoting signals, and is a key regulator of biosynthetic and metabolic pathways driving cell …